Clinical Trial Update: Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 safety study comparing TroVax alone versus TroVax plus Interferon Alpha in patients with renal cell carcinoma; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interferon-alpha (interferon alpha)
• TroVax

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED